Scientific journal
Научное обозрение. Медицинские науки
ISSN 2500-0780
ПИ №ФС77-57452

Personal portfolio

PECULIARITIES OF TREATMENT OF PATIENTS WITH VIRUS-ASSOCIATED LIVER CIRRHOSIS

Sapronova N.G. 1 Lukyanov S.V. 1 Chigaeva E.V. 1
1 «Rostov state medical University of the Ministry of health of Russia»
The analysis of treatment 341 patient with portal hypertension (PH) emissions of different Genesis. Of the 297 patients with intra-hepatic PH made 79 operations splenorenalis venous bypass (SVA) and 128 operations transyugularis intrahepatic portosystemicshuntings (TIPS). In addition sick run laparocentesis with reinfusion concentrate ascitic fluid (38). With the purpose of preoperative preparation, the elimination of Hypo - and dysproteinemia, as well as substitution therapy with interleukin-2 and prophylaxis of purulent complications with further surgical correction of PH in one of two ways associated with the risk of infection in 12 patients with HCV- cirrhosis complicated by ascites and symptoms of immune deficiency is the cell type of deficit CD3+- and CD4+-positive lymphocytes, decrease of CD4+CD25+-lymphocytes and NK cells performed laparocentesis with reinfusion concentrate ascitic fluid (application for invention «Method of treatment of patients with the syndrome of intra-hepatic portal hypertension» №2013128527, priority from 21.06.2013г.). After performing reinfusion before surgery no patient didn’t need the additional introduction of albumin, there was no evidence of purulent complications, postoperative wounds after СВШ healed primary tension, stabilized indicators biochemical blood tests.